Znanstveni rad - Pregledni rad
HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?
International Journal of Molecular Sciences, 24 (2023), 9; 8206. https://doi.org/10.3390/ijms24098206


Citirajte ovaj rad

Popović, M., Silovski, T., Križić, M. i Dedić Plavetić, N. (2023). HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?. International Journal of Molecular Sciences, 24. (9). doi: 10.3390/ijms24098206

Popović, Marina, et al. "HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?." International Journal of Molecular Sciences, vol. 24, br. 9, 2023. https://doi.org/10.3390/ijms24098206

Popović, Marina, Tajana Silovski, Marija Križić i Natalija Dedić Plavetić. "HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?." International Journal of Molecular Sciences 24, br. 9 (2023). https://doi.org/10.3390/ijms24098206

Popović, M., et al. (2023) 'HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?', International Journal of Molecular Sciences, 24(9). doi: 10.3390/ijms24098206

Popović M, Silovski T, Križić M, Dedić Plavetić N. HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?. International Journal of Molecular Sciences [Internet]. 04.05.2023. [pristupljeno 29.11.2024.];24(9). doi: 10.3390/ijms24098206

M. Popović, T. Silovski, M. Križić i N. Dedić Plavetić, "HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?", International Journal of Molecular Sciences, vol. 24, br. 9, Svibanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:211367. [Citirano: 29.11.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.